Search for: "Pfizer, Inc." Results 961 - 980 of 1,512
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Apr 2010, 7:05 pm by Gideon
Pfizer, Inc., 244 Conn. 598, 619 (1998) (McDonald, J., concurring) (Fourth  amendment law recognizes that the collective knowledge of the police determines probable cause. [read post]
15 Apr 2010, 5:09 am by Brian A. Comer
— South Carolina is to receive $11 million under an agreement with Pfizer Inc. over the company's disputed sales tactics for certain drugs, double the amount the state said Friday it would have gotten under a multistate deal struck last year.Under the deal finalized Thursday and confirmed by Pfizer, the New York-based pharmaceutical giant also is to give South Carolina more than $1.5 million in medications for use in its free clinics.In September, federal… [read post]
13 Apr 2010, 9:45 am by Daniel W. Whitney, Esquire
For example, in 2009, Pfizer Inc. reached a settlement with the federal government and states over allegations of health care fraud contained in nine qui tam cases. [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP Factor)… [read post]
7 Apr 2010, 4:23 am
A federal jury in Boston recently returned a verdict against Pfizer Inc. in connection with claims that Pfizer unlawfully promoted off-label uses of its anti-epilepsy drug Neurontin. [read post]
7 Apr 2010, 4:23 am
A federal jury in Boston recently returned a verdict against Pfizer Inc. in connection with claims that Pfizer unlawfully promoted off-label uses of its anti-epilepsy drug Neurontin. [read post]
5 Apr 2010, 7:23 pm by Altman & Altman
Pfizer Defends Epilepsy Drug Neurontin at Fraud Trial (Update3), BusinessWeek, March 23, 2010 Pfizer faces $142 million in damages for drug fraud, KBOI2.com/AP, March 26, 2010 Related Web Resources: Pfizer Neurontin [read post]
5 Apr 2010, 5:03 pm by mcarzima@imediainc.com
The suit was brought by Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals. [read post]
1 Apr 2010, 3:12 pm by Lebowitz & Mzhen
The F.D.A. sent letters last week to two major nitroglycerin drug makers, Konec Inc., and Glenmark Generics Inc., warning them that they must stop selling the unapproved drugs. [read post]
29 Mar 2010, 2:51 pm by brettb
A Boston jury last week ordered Pfizer Inc. to pay $47 million in damages in a lawsuit over its epilepsy drug Neurontin. [read post]
24 Mar 2010, 4:45 am
INPI (EPLAW) Lyrica (Pregabalin) – US: Patent infringement complaint filed following a Para IV certification: Pfizer Inc. et al. v. [read post]
11 Mar 2010, 9:59 pm by Patent Docs
District Court for the District of Columbia remanded Pfizer Inc.'s challenge of the USPTO's calculation of patent term adjustment (PTA) back to the U.S. [read post]
9 Mar 2010, 6:50 am by Queller, Fisher, Washor, Fuchs & Kool
One report from Pfizer Inc suggested that treating MRSA alone costs $4 billion per year, MSNBC reported. [read post]